Get started
Author

Jerel Boyd Vega

Observed names: Jerel B. Vega, Jerel Vega, Vega, Jerel
ORCID: 0000-0003-0998-4715
Observed ORCID: 0000-0003-0998-4715
OpenAlex ID: A5075783390
In vivo CAR T cell generation to treat cancer and autoimmune disease
2025 · Theresa L. Hunter, Yanjie Bao, et al. · Science · 393
Systemic delivery of factor IX messenger RNA for protein replacement therapy
2017 · Suvasini Ramaswamy, Nina Tonnu, et al. · Proceedings of the National Academy of Sciences · 314
PDF
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice
2021 · Ruklanthi de Alwis, Esther S. Gan, et al. · Molecular Therapy · 187
Development of an mRNA replacement therapy for phenylketonuria
2022 · Carlos G. Perez-Garcia, Ramon Diaz-Trelles, et al. · Molecular Therapy — Nucleic Acids · 69
PDF
Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines
2020 · Eric M. Mucker, Priya P. Karmali, et al. · Scientific Reports · 54
PDF
Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir
2023 · Marion Pardons, Basiel Cole, et al. · Nature Communications · 48
PDF
CD8 + T cells mediate protection against Zika virus induced by an NS3-based vaccine
2020 · Annie Elong Ngono, Thasneem Syed, et al. · Science Advances · 37
Anti-HFRS Human IgG Produced in Transchromosomic Bovines Has Potent Hantavirus Neutralizing Activity and Is Protective in Animal Models
2020 · Casey C. Perley, Rebecca L. Brocato, et al. · Frontiers in Microbiology · 30
PDF
Blood and tissue HIV-1 reservoirs display plasticity and lack of compartmentalization in virally suppressed people
2025 · Marion Pardons, Laurens Lambrechts, et al. · Nature Communications · 21
A truncated HIV Tat demonstrates potent and specific latency reversal activity
2023 · Ellen Van Gulck, Marion Pardons, et al. · Antimicrobial Agents and Chemotherapy · 19
Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets
2024 · Samuel L. M. Raines, Shane D. Falcinelli, et al. · Antimicrobial Agents and Chemotherapy · 12
PDF
Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model
2022 · Ramon Diaz-Trelles, Sharon Lee, et al. · Molecular Genetics and Metabolism Reports · 9
PDF
Correction for Raines et al., “Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets”
2025 · Samuel L. M. Raines, Shane D. Falcinelli, et al. · Antimicrobial Agents and Chemotherapy
Correction for Van Gulck et al., “A truncated HIV Tat demonstrates potent and specific latency reversal activity”
2024 · Ellen Van Gulck, Marion Pardons, et al. · Antimicrobial Agents and Chemotherapy
PDF
Works count: 15
Citation count: 1,193
H-index: 11
I10-index: 11
Year
Topic
Type